Kuros Biosciences AG (FRA:YTSN)

Germany flag Germany · Delayed Price · Currency is EUR
32.04
-0.02 (-0.06%)
At close: Dec 4, 2025
2.82%
Market Cap 1.28B
Revenue (ttm) 110.66M
Net Income (ttm) -6.50M
Shares Out n/a
EPS (ttm) -0.14
PE Ratio n/a
Forward PE 88.21
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 1
Open 32.04
Previous Close 32.06
Day's Range 32.04 - 32.04
52-Week Range 23.32 - 35.32
Beta n/a
RSI 57.54
Earnings Date Mar 10, 2026

About Kuros Biosciences AG

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bon... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2016
Employees 122
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol YTSN
Full Company Profile

Financial Performance

In 2024, Kuros Biosciences AG's revenue was 75.56 million, an increase of 125.11% compared to the previous year's 33.56 million. Losses were -4.29 million, -68.75% less than in 2023.

Financial numbers in CHF Financial Statements

News

There is no news available yet.